Literature DB >> 33472827

Heparanome-Mediated Rescue of Oligodendrocyte Progenitor Quiescence following Inflammatory Demyelination.

Darpan Saraswat1, R Ross Welliver1, Roopa Ravichandar1, Ajai Tripathi2, Jessie J Polanco3, Jacqueline Broome1, Edward Hurley4, Ranjan Dutta2, M Laura Feltri4, Fraser J Sim5,3.   

Abstract

The proinflammatory cytokine IFN-γ, which is chronically elevated in multiple sclerosis, induces pathologic quiescence in human oligodendrocyte progenitor cells (OPCs) via upregulation of the transcription factor PRRX1. In this study using animals of both sexes, we investigated the role of heparan sulfate proteoglycans in the modulation of IFN-γ signaling following demyelination. We found that IFN-γ profoundly impaired OPC proliferation and recruitment following adult spinal cord demyelination. IFN-γ-induced quiescence was mediated by direct signaling in OPCs as conditional genetic ablation of IFNγR1 (Ifngr1) in adult NG2+ OPCs completely abrogated these inhibitory effects. Intriguingly, OPC-specific IFN-γ signaling contributed to failed oligodendrocyte differentiation, which was associated with hyperactive Wnt/Bmp target gene expression in OPCs. We found that PI-88, a heparan sulfate mimetic, directly antagonized IFN-γ to rescue human OPC proliferation and differentiation in vitro and blocked the IFN-γ-mediated inhibitory effects on OPC recruitment in vivo Importantly, heparanase modulation by PI-88 or OGT2155 in demyelinated lesions rescued IFN-γ-mediated axonal damage and demyelination. In addition to OPC-specific effects, IFN-γ-augmented lesions were characterized by increased size, reactive astrogliosis, and proinflammatory microglial/macrophage activation along with exacerbated axonal injury and cell death. Heparanase inhibitor treatment rescued many of the negative IFN-γ-induced sequelae suggesting a profound modulation of the lesion environment. Together, these results suggest that the modulation of the heparanome represents a rational approach to mitigate the negative effects of proinflammatory signaling and rescuing pathologic quiescence in the inflamed and demyelinated human brain.SIGNIFICANCE STATEMENT The failure of remyelination in multiple sclerosis contributes to neurologic dysfunction and neurodegeneration. The activation and proliferation of oligodendrocyte progenitor cells (OPCs) is a necessary step in the recruitment phase of remyelination. Here, we show that the proinflammatory cytokine interferon-γ directly acts on OPCs to induce pathologic quiescence and thereby limit recruitment following demyelination. Heparan sulfate is a highly structured sulfated carbohydrate polymer that is present on the cell surface and regulates several aspects of the signaling microenvironment. We find that pathologic interferon-γ can be blocked by modulation of the heparanome following demyelination using either a heparan mimetic or by treatment with heparanase inhibitor. These studies establish the potential for modulation of heparanome as a regenerative approach in demyelinating disease.
Copyright © 2021 the authors.

Entities:  

Keywords:  demyelination; human; interferon; oligodendrocyte progenitor; quiescence; remyelination

Year:  2021        PMID: 33472827      PMCID: PMC8018763          DOI: 10.1523/JNEUROSCI.0580-20.2021

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  96 in total

1.  Expression of heparanase in vascular cells and astrocytes of the mouse brain after focal cerebral ischemia.

Authors:  Jimei Li; Jin-Ping Li; Xiao Zhang; Zhongyang Lu; Shan Ping Yu; Ling Wei
Journal:  Brain Res       Date:  2011-11-19       Impact factor: 3.252

2.  Heparan sulfate mimicry: a synthetic glycoconjugate that recognizes the heparin binding domain of interferon-gamma inhibits the cytokine activity.

Authors:  Stéphane Sarrazin; David Bonnaffé; André Lubineau; Hugues Lortat-Jacob
Journal:  J Biol Chem       Date:  2005-09-09       Impact factor: 5.157

3.  MEK-ERK signaling is involved in interferon-gamma-induced death of oligodendroglial progenitor cells.

Authors:  Makoto Horiuchi; Aki Itoh; David Pleasure; Takayuki Itoh
Journal:  J Biol Chem       Date:  2006-05-25       Impact factor: 5.157

4.  Age-dependent fate and lineage restriction of single NG2 cells.

Authors:  Xiaoqin Zhu; Robert A Hill; Dirk Dietrich; Mila Komitova; Ryusuke Suzuki; Akiko Nishiyama
Journal:  Development       Date:  2011-02       Impact factor: 6.868

5.  Bone morphogenetic proteins induce astroglial differentiation of oligodendroglial-astroglial progenitor cells.

Authors:  P C Mabie; M F Mehler; R Marmur; A Papavasiliou; Q Song; J A Kessler
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

6.  Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways.

Authors:  Porfirio Nava; Stefan Koch; Mike G Laukoetter; Winston Y Lee; Keli Kolegraff; Christopher T Capaldo; Neal Beeman; Caroline Addis; Kirsten Gerner-Smidt; Irmgard Neumaier; Arne Skerra; Linheng Li; Charles A Parkos; Asma Nusrat
Journal:  Immunity       Date:  2010-03-18       Impact factor: 31.745

7.  STAT1/IRF-1 signaling pathway mediates the injurious effect of interferon-gamma on oligodendrocyte progenitor cells.

Authors:  Yan Wang; Zhihua Ren; Duan Tao; Shilpa Tilwalli; Rajendra Goswami; Roumen Balabanov
Journal:  Glia       Date:  2010-01-15       Impact factor: 7.452

Review 8.  Astrocytes: biology and pathology.

Authors:  Michael V Sofroniew; Harry V Vinters
Journal:  Acta Neuropathol       Date:  2009-12-10       Impact factor: 17.088

9.  Exacerbations of multiple sclerosis in patients treated with gamma interferon.

Authors:  H S Panitch; R L Hirsch; A S Haley; K P Johnson
Journal:  Lancet       Date:  1987-04-18       Impact factor: 79.321

Review 10.  The effects of interferon-gamma on the central nervous system.

Authors:  B Popko; J G Corbin; K D Baerwald; J Dupree; A M Garcia
Journal:  Mol Neurobiol       Date:  1997 Feb-Apr       Impact factor: 5.590

View more
  2 in total

1.  Reactive Astrocytes Derived From Human Induced Pluripotent Stem Cells Suppress Oligodendrocyte Precursor Cell Differentiation.

Authors:  Matthew D Smith; Xitiz Chamling; Alexander J Gill; Hector Martinez; Weifeng Li; Kathryn C Fitzgerald; Elias S Sotirchos; Dorota Moroziewicz; Lauren Bauer; Daniel Paull; Marjan Gharagozloo; Pavan Bhargava; Donald J Zack; Valentina Fossati; Peter A Calabresi
Journal:  Front Mol Neurosci       Date:  2022-05-06       Impact factor: 6.261

2.  Ruxolitinib attenuates secondary injury after traumatic spinal cord injury.

Authors:  Zhan-Yang Qian; Ren-Yi Kong; Sheng Zhang; Bin-Yu Wang; Jie Chang; Jiang Cao; Chao-Qin Wu; Zi-Yan Huang; Ao Duan; Hai-Jun Li; Lei Yang; Xiao-Jian Cao
Journal:  Neural Regen Res       Date:  2022-09       Impact factor: 5.135

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.